It is suggested that the reason behind this is because Olympus’ imaging business is making a loss because in the financial report released this week, Olympus’ medical instrument business has made a profit of 8.02 billion Yen, versus their imaging business which actually saw the company lose about 23.07 billioon Yen. Considering that many smartphones these days have the capabilities of taking some pretty good quality images, we guess it’s not surprising that customers would rather invest in a higher-end camera that can do things their phone cameras can’t, versus a low-end P&S whose quality difference between smartphones is debatable.